These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 19047290)

  • 41. [Minimally invasive surgery of neural tumors in childhood].
    Crehuet Gramatyka D; Gómez-Chacón Villalba J; Cortés Sáez J; Marco Macián A; Vila Carbó JJ
    Cir Pediatr; 2018 Aug; 31(3):140-145. PubMed ID: 30260107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JNBSG).
    Ohira M; Nakamura Y; Takimoto T; Nakazawa A; Hishiki T; Matsumoto K; Shichino H; Iehara T; Nagase H; Fukushima T; Yoneda A; Tajiri T; Nakagawara A; Kamijo T
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
    Iehara T; Yoneda A; Yokota I; Takahashi H; Teramukai S; Kamijyo T; Nakazawa A; Takimoto T; Kikuta A; Yagyu S; Ikeda H; Nakagawara A; Tajiri T;
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27914. PubMed ID: 31342649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Association of Clinical Characteristics and Tumour Markers With Image-Defined Risk Factors in the Management of Neuroblastoma in South Africa.
    van Heerden J; Esterhuizen TM; Hendricks M; Poole J; Büchner A; Naidu G; du Plessis J; van Emmenes B; van Zyl A; Mathews E; Kruger M;
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e149-e159. PubMed ID: 34750056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An
    Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
    Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study.
    Espinoza AF; Bagatell R; McHugh K; Naranjo AH; Van Ryn C; Rojas Y; Lyons K; Guillerman RP; Kirby C; Brock P; Volchenboum S; Simon T; States L; Miller A; Krug B; Sarnacki S; Irtan S; Brisse HJ; Valteau-Couanet D; von Schweinitz D; Kammer B; Granata C; Pio L; Park JR; Nuchtern JG
    Pediatr Blood Cancer; 2024 Oct; 71(10):e31218. PubMed ID: 39072986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience with International Neuroblastoma Staging System and Pathology Classification.
    Ikeda H; Iehara T; Tsuchida Y; Kaneko M; Hata J; Naito H; Iwafuchi M; Ohnuma N; Mugishima H; Toyoda Y; Hamazaki M; Mimaya J; Kondo S; Kawa K; Okada A; Hiyama E; Suita S; Takamatsu H
    Br J Cancer; 2002 Apr; 86(7):1110-6. PubMed ID: 11953858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between image-defined risk factors and neuroblastoma outcomes.
    Phelps HM; Ndolo JM; Van Arendonk KJ; Chen H; Dietrich HL; Watson KD; Hilmes MA; Chung DH; Lovvorn HN
    J Pediatr Surg; 2019 Jun; 54(6):1184-1191. PubMed ID: 30885556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
    Morgenstern DA; London WB; Stephens D; Volchenboum SL; Hero B; Di Cataldo A; Nakagawara A; Shimada H; Ambros PF; Matthay KK; Cohn SL; Pearson AD; Irwin MS
    J Clin Oncol; 2014 Apr; 32(12):1228-35. PubMed ID: 24663047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma.
    Günther P; Holland-Cunz S; Schupp CJ; Stockklausner C; Hinz U; Schenk JP
    Eur J Pediatr Surg; 2011 Oct; 21(5):314-7. PubMed ID: 21780020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
    Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
    Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of image-defined risk factors in predicting surgical complications of localized neuroblastoma.
    Liu T; Lv Z; Xu W; Liu J; Sheng Q
    Pediatr Surg Int; 2020 Oct; 36(10):1167-1172. PubMed ID: 32851471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis.
    Morin CE; Hasweh R; Anton C; Dillman JR; Orscheln E; Smith EA; Kotagal M; Weiss BD; Ouyang J; Zhang B; Trout AT; Towbin AJ
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30724. PubMed ID: 37845799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
    Castel V; García-Miguel P; Cañete A; Melero C; Navajas A; Ruíz-Jiménez JI; Navarro S; Badal MD
    Eur J Cancer; 1999 Apr; 35(4):606-11. PubMed ID: 10492635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
    Brown EG; Adkins ES; Mattei P; Hoffer FA; Wootton-Gorges SL; London WB; Naranjo A; Schmidt ML; Hogarty MD; Irwin MS; Cohn SL; Park JR; Maris JM; Bagatell R; Twist CJ; Nuchtern JG; Davidoff AM; Newman EA; Lal DR
    J Pediatr Surg; 2024 Sep; ():161896. PubMed ID: 39317567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
    Moroz V; Machin D; Faldum A; Hero B; Iehara T; Mosseri V; Ladenstein R; De Bernardi B; Rubie H; Berthold F; Matthay KK; Monclair T; Ambros PF; Pearson AD; Cohn SL; London WB
    Eur J Cancer; 2011 Mar; 47(4):561-71. PubMed ID: 21112770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of surgery in stage IV neuroblastoma.
    Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
    J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.